[Form 4] SHERWIN WILLIAMS CO Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Sherwin-Williams (SHW) reported an insider equity award on Form 4. The company granted its SVP–Finance & CFO an employee stock option for 16,920 shares at an exercise price of $331.37 per share on October 20, 2025, under the 2025 Equity and Incentive Compensation Plan.
The options vest annually in three substantially equal installments commencing October 20, 2026, and carry an expiration date of October 19, 2035. Following the reported transaction, the reporting person holds 16,920 derivative securities directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Mistysyn Allen J
Role
SVP - Finance & CFO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Buy) | 16,920 | $0.00 | -- |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 16,920 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did Sherwin-Williams (SHW) disclose on this Form 4?
An employee stock option grant to the SVP–Finance & CFO for 16,920 shares at an exercise price of $331.37 per share.
How many Sherwin-Williams options were granted and at what price?
The grant was for 16,920 options with an exercise price of $331.37 per share.
When do the SHW options vest for the CFO?
They vest annually in three substantially equal installments commencing October 20, 2026.
What is the expiration date of the SHW options?
The options expire on October 19, 2035.
What plan governs the option grant?
The grant was made under Sherwin-Williams’ 2025 Equity and Incentive Compensation Plan.
How many derivative securities does the reporting person own after the transaction?
The reporting person beneficially owns 16,920 derivative securities directly following the transaction.
Who signed the filing for the reporting person?
It was signed by Stephen J. Perisutti, attorney-in-fact, on October 22, 2025.